21 October 2022 World New Deal Boosts Access To Generic Chronic Myeloid Leukaemia Drug A licence agreement between the Medicines Patent Pool (MPP) and Novartis will allow manufacturers to produce and supply generic versions of nilotinib.
12 September 2019 World Scientists Use Gene-Editing In Bid To Treat Man’s Leukaemia, HIV The effort uses the same technology as last year’s highly controversial experiment by scientist He Jiankui.